Haemophilia

Papers
(The H4-Index of Haemophilia is 20. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-08-01 to 2026-08-01.)
ArticleCitations
AHP Oral Abstracts47
The effects of emicizumab on in vitro coagulation and fibrinolysis parameters in patients with disseminated intravascular coagulation with and without addition of anti‐FVIII antibody40
The detrimental effects of iron to the joint; aggravation by inflammation37
Effectiveness of therapeutic exercise and cognitive‐behavioural therapy combined protocol on functionality, pain and joint health in people with haemophilia: Secondary analysis of a controlled trial34
Recommendations for Psychosocial Support during Gene Therapy: Results From an EAHAD Interdisciplinary Roundtable33
13th BIC International Conference33
The importance and evolution of bleeding disorder registries33
New Treatment in Haemophilia: Challenges, Controversies and Uncertainties32
A systematic review of adeno‐associated virus gene therapy clinical trials for HIV – A potential solution for patients with haemophilia and HIV?31
Developing a Two‐Sided Decision Box to Facilitate Shared Decision‐Making for Switching From Conventional to Pharmacokinetic‐Tailored Prophylaxis in Haemophilia30
Competence and Confidence: An Evaluation of Physiotherapists' Knowledge and Self‐Perception About Physical Activity and Exercise in Patients With Haemophilia30
CCS_Book of abstracts28
Platelet Hyperreactivity May Contribute to Thrombotic Complications in Afibrinogenemia: A Case‐Based Observation27
How to assess, detect, and manage joint involvement in the era of transformational therapies: Role of point‐of‐care ultrasound26
Targeting higher factor VIII levels for prophylaxis in haemophilia A: a narrative review25
Haemophilia B, severe childhood obesity and other extra‐haematological features associated with similar 4Mb‐deletions on Xq27: Clinical findings, molecular insights and literature update24
Wearable activity trackers in young people with haemophilia: What needs to be considered?21
Reinvestigation of unidentified causative variants in FXI‐deficient patients: Focus on gene segment deletions21
Initial von Willebrand factor antigen values in adolescent females predict future values20
Test–retest reliability of a mobile application of the patient reported outcomes burdens and experiences (PROBE) study20
0.12161707878113